The Effect of Atrial Septal Defect in the Treatment of ARDS with Left Ventricular Dysfunction Simulating Severe COVID-19
Keywords:COVID-19, Acute Respiratory Distress Syndrome, Left Ventricular Dysfunction, Atrial Septal Defect, Extracorporeal Membrane Oxygenation, Large Animal Experiments
Objective: To explore the effect of atrial septal defect (ASD) and venoarterial extracorporeal membrane oxygenation (VA-ECMO) in the treatment of ARDS combined with left ventricular dysfunction (LVD) to find a new effective method for treating severe COVID-19 patients.
Materials and methods: Five large animal ARDS models of sheep were established by intravenous injection of
Lipopolysaccharide. ASD was made under general anesthesia and VA-ECMO was simulated by extracorporeal circulation machine. The oxygenation of peripheral blood, systemic circulation, and cardiac function were observed under conditions of closed and opened ASD, and the significance of ASD shunt in improving cardiopulmonary function was evaluated.
Results: With ASD closed, the atrial shunts disappeared, the peripheral artery pressure of oxygen(PaO2): 141.2±21.4mmHg, the oxygenation index (PaO2/FiO2): 353.0±53.5, the mean blood pressure (MAP): 49.3±13.5 mmHg, the heart was full; with ASD opened, the left-to-right shunt was observed, PaO2: 169.3±18.9mmHg, PaO2/FiO2: 423.3±47.3, MAP: 68.2±16.1 mmHg, the range of cardiac motion significantly increased, heart beat was powerful, and systemic circulation significantly improved. Statistical analysis showed that there were significant differences between opened and closed ASD (P < .01).
Conclusion: ASD plus VA-ECMO is an effective method for the treatment of ARDS combined with LVD, which is the main cause of death in severe COVID-19 patients. However, further clinical validation is needed.
Baruteau AE, Barnetche T, Morin L, et al. 2018. Percutaneous balloon atrial septostomy on top of venoarterial extracorporeal membrane oxygenation results in safe and effective left heart decompression. Eur Heart J Acute Cardiovasc Care 7:70-79.
Brann SH, Thomas CN, Rose SS, et al. 2000. The feasibility of a porcine model of acute coronary occlusion and reperfusion using off-pump coronary artery bypass grafting. West Indian Med J 49:271-275.
Dahdouh Z, Roule V, Lognone T, et al. 2013. Atrial septostomy in cardiogenic shock related to H1N1 infection. Acute Card Care 15:7-9.
Dahdouh Z, Roule V, Lognone T, Sabatier R, Grollier G. 2012. Percutaneous blade and balloon atrioseptostomy as a supplement to extracorporeal membrane oxygenation as a bridge to heart transplantation. Cardiovasc Revasc Med 13:69–71.
Franklin M, McGough E, Peng Y. 2019. Percutaneous mechanical devices for supporting the left ventricular failure. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 44(4):354–363.
Geva T, Martins JD, Wald RM. 2014. Atrial septal defects. Lancet. 383(9932):1921-1932.
Kon ZN, Bittle GJ, Pasrija C, et al. 2017. Venovenous Versus Venoarterial Extracorporeal Membrane Oxygenation for Adult Patients With Acute Respiratory Distress Syndrome Requiring Precannulation Hemodynamic Support: A Review of the ELSO Registry. Ann Thorac Surg 104:645-649.
Lin YN, Chen YH, Wang HJ, et al. 2017. Atrial Septostomy for Left Atrial Decompression During Extracorporeal Membrane Oxygenation by Inoue Balloon Catheter. Circ J 81:1419-1423.
Meuwese CL, de Haan M, Zwetsloot PP, et al. 2020. The hemodynamic effect of different left ventricular unloading techniques during veno-arterial extracorporeal life support: a systematic review and meta-analysis. Perfusion 267659119897478.
Millar JE, Bartnikowski N, von Bahr V, et al. 2019. Extracorporeal membrane oxygenation (ECMO) and the acute respiratory distress syndrome (ARDS): a systematic review of pre-clinical models. Intensive Care Med Exp. 7(1):18. Published Mar 25.
Ramanathan K, Antognini D, Combes A, et al. 2020. Planning and provision of ECMO services for severe ARDS during the COVID-19 pandemic and other outbreaks of emerging infectious diseases. Lancet Respir Med.
Xu Z, Shi L, Wang Y, et al. 2020. PATHOLOGIC findings of COVID-19 associated with acute Respiratory distress syndrome, The Lancet Respiratory Medicine.
Yang X, Yu Y, Xu J. 2020. Clinical course and outcomes of critically patients with SARS-CoV-2 pneumonia in Wuhan, China: A single-centered, retrospective, study, The Lancet Respiratory medicinal.
Yi K, Xu J, You T, Hou X, Ma L, Wang D, Yang K. 2019. Comparison of efficacy of percutaneous transcatheter closure of atrial septal defect by radiation-guided versus ultrasound-guided transcatheter closure: A Meta-analysis. Chinese Journal of Heart and Lung Disease, 3805:573-580.
Yuan Z, Bedi B. 2018. Bronchoalveolar Lavage Exosomes in ipopolysaccharide-induced Septic Lung Injury. J Vis Exp.
Zhang C, Huang S, Zheng F. 2020. Controversial treatments: an updated understanding of the Coronavirus Disease 2019. J Med Virol.
Zhang H, Chao Y, Ma S, et al. 1999. A sheep Acute respiratory distress syndrome model was established by intravenous injection of endotoxin under anesthesia. Critical Care Medicine in China 02:13-15.
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B. 2020. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. Published online March 9.